Proseek Bio welcomes Peter Bradley to its Board as Non-Executive Director

Proseek Bio is pleased to announce the appointment of Peter Bradley as Non-Executive Director.

Peter brings extensive leadership experience across the biotechnology, medical technology, and life sciences sectors, with a strong track record of supporting innovation, commercial growth, and strategic development.

His appointment strengthens Proseek Bio's Board as the company continues to advance diagnostics designed to improve earlier detection and clinical decision-making in ovarian cancer.

Peter's experience will provide valuable strategic oversight and governance as Proseek Bio progresses through the next stage of growth.

We are delighted to welcome Peter to the Board and look forward to his contribution as we continue our mission to improve outcomes for women through innovative diagnostics.